Investor Agrees To Drop FedEx Drug Shipping Derivative Suit
A FedEx Corp. investor has agreed to drop a shareholder derivative suit filed against the FedEx CEO and board that claimed the company knowingly shipped illegal drugs from online pharmacies, in...To view the full article, register now.
Already a subscriber? Click here to view full article